Skip to main content
Clinical Trials/ISRCTN11220163
ISRCTN11220163
Completed
未知

Improving outcome measures for physiotherapy trials of airway clearance in adults with cystic fibrosis

Royal Brompton & Harefield NHS Foundation Trust0 sites68 target enrollmentSeptember 19, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Cystic fibrosis
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Enrollment
68
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33020113/ protocol (added 08/10/2020) 2022 Abstract results in https://doi.org/10.1016/S1569-1993(22)00848-7 Presented at North American Cystic Fibrosis Conference (added 01/08/2023)

Registry
who.int
Start Date
September 19, 2016
End Date
October 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of Cystic Fibrosis (confirmed by standard criteria)
  • 2\. Aged 16 years or over
  • 3\. Registered as patients of the Royal Brompton Hospital

Exclusion Criteria

  • 1\. Evidence of pulmonary exacerbation within 3 weeks prior to screening
  • 2\. Any change in a chronic treatment/prophylaxis regimen for CF or CF\-related condition within 4 weeks of visit Current infective exacerbation or reduction in lung function requiring therapeutic intervention
  • 3\. Current moderate haemoptysis (greater than streaking in the sputum)
  • 4\. Current dependency on positive pressure support with ACT Previous history of spontaneous rib fractures
  • 5\. Pregnancy Inability to give consent for treatment or measurement
  • 6\. Current dependency upon non\-invasive ventilation Current dependency upon oxygen therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials